Monday, April 6, 2020

Infanrix Hexa

Independent media sources have procured an eye-opening treasure trove of bombshell information showing that vaccine giant GlaxoSmithKline (GSK) knew full well that a 6-in-1 vaccine it produces caused at least 36 infants who received it to die over the course of two years, but failed to disclose this pertinent information publicly.

The combination vaccine, known as “Infanrix Hexa,” resulted in almost immediate death for these 36 young ones, a previously withheld 1,271-page document that was first obtained by the website Initiative Citoyenne reveals. These deaths reportedly occurred between October 2009 and October 2011.

Originally launched in 2000, Infanrix Hexa is a multivalent vaccine that’s marketed as a jab that protects against diphtheria, tetanus, pertussis (whooping cough), polio, hepatitis B, and Haemophilus influenzae type b (Hib). According to GSK, Infanrix Hexa is completely safe and effective – which we now know, thanks to this newly-leaked document, is factually incorrect.

Computational figures compiled by GreenMedInfo‘s Christina England, an investigative sleuth who’s uncovered all sorts of problems with many so-called “combination vaccines,” reveal that Infanrix Hexa is hardly safe or effective, and is actually a very high-risk vaccine, even by vaccine industry standards.

“Using the figure of 36 deaths over a two-year period, this averages 1.5 deaths per month, which by anyone’s standard is extremely high,” she writes. “Note that only 1 to 10% of adverse reactions to vaccines are actually reported. Therefore, in reality, the problem could potentially be far more serious and the actual number of fatalities much higher.”

No comments:

Post a Comment